Key result
This review discusses the incidence, risk factors, and management of device-related thrombus after left atrial appendage closure, emphasizing individualized multidisciplinary decision-making.
Why the study?
What are the incidence, risk factors, and management strategies for device-related thrombus after left atrial appendage closure in patients with AF?
What are the incidence, risk factors, and management strategies for device-related thrombus after left atrial appendage closure in patients with AF?
Device-related thrombus after LAAC is a significant complication associated with increased stroke risk, requiring individualized multidisciplinary management strategies.
Although left atrial appendage closure (LAAC) has proved non-inferior to oral anticoagulants in patients with AF, there has been recent concern about the occurrence of late complications, especially device-related thrombus (DRT), which was associated with increased risk of stroke. In this article, the incidence, risk factors and time course of DRT after LAAC are discussed, as well as the potential benefits of dedicated strategies in the management of DRT, which remain speculative, especially in patients with a contraindication to oral anticoagulants. In these patients, decision-making should be based on a multidisciplinary evaluation of the ischaemic/bleeding balance on an individual basis.
No takes yet. Share an insight, caveat, or question.
Garot et al. (2018) conducted a review in Atrial Fibrillation. Left atrial appendage closure (LAAC) was evaluated. This review discusses the incidence, risk factors, and management of device-related thrombus after left atrial appendage closure, emphasizing individualized multidisciplinary decision-making.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: